Cargando…
COVID-19 and Thromboinflammation: Is There a Role for Statins?
The novel coronavirus disease (COVID-19) showed increased morbidity and mortality rates and worse prognosis in individuals with underlying chronic diseases, especially cardiovascular disease and its risk factors, such as hypertension, diabetes, and obesity. There is also evidence of possible links a...
Autores principales: | Ferrari, Filipe, Martins, Vítor M., Teixeira, Marcelo, Santos, Raul D., Stein, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955154/ https://www.ncbi.nlm.nih.gov/pubmed/33787678 http://dx.doi.org/10.6061/clinics/2021/e2518 |
Ejemplares similares
-
Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020) -
Thromboinflammation in COVID-19 acute lung injury
por: Mitchell, William Beau
Publicado: (2020) -
Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation
por: Lind, Stuart E.
Publicado: (2021) -
Thromboinflammation and COVID-19: The Role of Exercise in the Prevention and Treatment
por: Batatinha, Helena Angelica Pereira, et al.
Publicado: (2020) -
Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences
por: Martins-Gonçalves, Remy, et al.
Publicado: (2023)